OBJECTIVE: Clinical trials are indispensable to drug approval process. This research examined the effect of a specific study criteria on recruitment and generalizability of the results. METHODS: The following were reviewed: (a) the usual inclusion and exclusion criteria for the antipsychotic trials performed at the Institute; (b) epidemiologic data, to determine the effect of study criteria on the target population; and (c) the recruitment procedures/strategies used to identify potential candidates. A survey was conducted to determine the percentage of schizophrenic patients in a conventional outpatient psychiatric clinic conforming to the usual enrollment criteria for antipsychotic trials. RESULTS: Intensive recruitment efforts in a general population of 3.6 million would have been expected to yield only 632 eligible subjects out of 36,000 suffering from schizophrenia. Out of 632, only 50 contacted the research site after an intensive recruitment effort. From those 50, 30 were excluded during a telephone interview. Of the 20 remaining, 6 were excluded for a variety of reasons during a face-to-face interview. Thus, only 14 subjects out of a population of 3.6 million met the study criteria. CONCLUSIONS: These results emphasize the rarified nature of patients-volunteers who enter a clinical trial. Inclusion and exclusion study criteria can severely restrict the number of eligible subjects, dictate recruitment strategies, and in turn affect generalizability of the results.
OBJECTIVE: Clinical trials are indispensable to drug approval process. This research examined the effect of a specific study criteria on recruitment and generalizability of the results. METHODS: The following were reviewed: (a) the usual inclusion and exclusion criteria for the antipsychotic trials performed at the Institute; (b) epidemiologic data, to determine the effect of study criteria on the target population; and (c) the recruitment procedures/strategies used to identify potential candidates. A survey was conducted to determine the percentage of schizophrenicpatients in a conventional outpatientpsychiatric clinic conforming to the usual enrollment criteria for antipsychotic trials. RESULTS: Intensive recruitment efforts in a general population of 3.6 million would have been expected to yield only 632 eligible subjects out of 36,000 suffering from schizophrenia. Out of 632, only 50 contacted the research site after an intensive recruitment effort. From those 50, 30 were excluded during a telephone interview. Of the 20 remaining, 6 were excluded for a variety of reasons during a face-to-face interview. Thus, only 14 subjects out of a population of 3.6 million met the study criteria. CONCLUSIONS: These results emphasize the rarified nature of patients-volunteers who enter a clinical trial. Inclusion and exclusion study criteria can severely restrict the number of eligible subjects, dictate recruitment strategies, and in turn affect generalizability of the results.
Authors: Rob Kirkhart; Niraj Ahuja; Joseph Wy Lee; Jose Ramirez; Rebecca Talbert; Kishwer Faiz; Gabor S Ungvari; Christopher Thomas; Brendan T Carroll Journal: Psychiatry (Edgmont) Date: 2007-09
Authors: Emily Kline; Victoria Hendel; Michelle Friedman-Yakoobian; Raquelle I Mesholam-Gately; Ann Findeisen; Suzanna Zimmet; Joanne D Wojcik; Tracey L Petryshen; Tsung-Ung W Woo; Jill M Goldstein; Martha E Shenton; Matcheri S Keshavan; Robert W McCarley; Larry J Seidman Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2018-11-28 Impact factor: 4.328
Authors: Yassine Ochen; Reinier B Beks; Mark van Heijl; Falco Hietbrink; Luke P H Leenen; Detlef van der Velde; Marilyn Heng; Olivier van der Meijden; Rolf H H Groenwold; R Marijn Houwert Journal: BMJ Date: 2019-01-07
Authors: James D Millard; Lawrence Muhangi; Moses Sewankambo; Juliet Ndibazza; Alison M Elliott; Emily L Webb Journal: Trials Date: 2014-08-06 Impact factor: 2.279